Incidence and Management of Olaratumab Infusion-Related Reactions

PURPOSE: Olaratumab is a human monoclonal immunoglobulin G1 antibody against platelet-derived growth factor receptor-α. We report the nature and frequency of infusion-related reactions (IRRs) with olaratumab in clinical trials and postmarketing reports. METHODS: Data from patients exposed to olaratu...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Tine, Brian A., Govindarajan, Rangaswamy, Attia, Steven, Somaiah, Neeta, Barker, Scott S., Shahir, Ashwin, Barrett, Emily, Lee, Pablo, Wacheck, Volker, Ramage, Samuel C., Tap, William D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2019
Materias:
ORIGINAL CONTRIBUTIONS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851793/
https://www.ncbi.nlm.nih.gov/pubmed/31268811
http://dx.doi.org/10.1200/JOP.18.00761

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851793/
https://www.ncbi.nlm.nih.gov/pubmed/31268811
http://dx.doi.org/10.1200/JOP.18.00761

Ejemplares similares